Skip to content

Clinical trials

Terminated Carcinoma, Hepatocellular trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Terminated Country / region: Belgium Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20082
20101
20113
20121
20142
20171
20181
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
University Hospital, Ghent2
Abbott1
Astellas Pharma Inc1
BTG International Inc.1
Boston Scientific Corporation1
European Organisation for Research and Treatment of Cancer - EORTC1
Genoscience Pharma1
Jules Bordet Institute1
Merit Medical Systems, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular15
Liver Neoplasms4
Neoplasms3
Cholangiocarcinoma2
Colorectal Neoplasms2
Ovarian Neoplasms2
Acrocephalosyndactylia1
Adenocarcinoma1
Bile Duct Neoplasms1
Carcinoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.